FDA Issues EUA for GenScript’s Test Detecting Neutralizing Antibodies from COVID-19
The serology test is the first of its kind to detect neutralizing antibodies from a recent or prior SARS-CoV-2 infection.
The serology test is the first of its kind to detect neutralizing antibodies from a recent or prior SARS-CoV-2 infection.
Healthcare alliance group Premier discusses six issues that are at the forefront in the context of the 2020 election.
The pandemic is helping realize the potential of ISO IDMP data standards in relation to adverse event reporting, electronic prescribing and medicines control in the supply chain.
The PCR and real-time PCR molecular diagnostics was valued at $4 billion in 2019.
Adopting new technology to ensure the health and safety of patients shouldn’t adversely affect security and privacy.
Medical device security needs to address the cyber-physical threats, not just patient health information risk.
Jennifer Fried, CEO of ExplORer Surgical, explains the stress that COVID-19 has placed on healthcare and the shift in how medical device reps are connecting with hospitals and healthcare providers.
The pandemic has revealed some inadequacies in the way medical device suppliers manage regulated product information. The following is a look back on a challenging year and suggestions for practical improvements to cope with continued uncertainty in 2021.
To achieve success in this market, device manufacturers should consider working with providers to help contain costs and enhance outcomes.
No longer just “the big company advantage,” Arlen Ward discusses how CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.